Pernix Therapeutics Holdings (PTX) Posts Q3 Loss of 1c/Share

Pernix Therapeutics Holdings (NYSE: PTX) reported Q3 EPS of ($0.01), $0.04 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $18.1 million versus the consensus estimate of $15.04 million.

For earnings history and earnings-related data on Pernix Therapeutics Holdings (PTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Minerva Neurosciences (NERV) Tops Q2 EPS by 5c
• Hawaiian Electric Industries (HE) Misses Q2 EPS by 6c